* Image shown for reference purposes only. Actual product appearance may vary. Please read product description for full and accurate details.
By OHC
MSRP $1,063.30 You Save $377.30
Sold & Shipped by Jant Pharmacal | |
In Stock | |
Typically Ships Within 3 day(s) | |
Price Match Guarantee | |
Calculate shipping | |
See Product Restrictions Below |
OHC COVID-19 Antigen Self Test 2 Tests/Kit
Extended Expiration Date: 11/23 -12/23
The OHC COVID-19 Antigen Self Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal (nares) swabs from individuals when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.
The OHC COVID-19 Antigen Self Test
FDA Emergency Use Authorized
91% relative sensitivity and 99% relative specificity*
Features & Benefits:
- Detects both Omicron and Delta variants
- Children starting at the age of 14 can self test. Children from ages 2 to 13 require the help of an adult
- Uses minimally invasive shallow nasal swab
- Easy visual read
- Fast results in ~ 15 minutes
- Relative Sensitivity: 91% ( 95% CI: 82.8 to 95.6%); Relative Specificity: 99% (95% CI: 95.2 to 99.6%)*
- Room temperature storage
Prevent your loved ones from exposure to the virus with the accuracy of the OHC COVID-19 Antigen Self Test.
OHC continues to conduct studies for SARS-CoV-2 as new variants continue to emerge so that we can provide high-quality testing for you and your family.
Using the easy nasal swab test, you can self-collect samples with highly accurate and reliable results you can expect in just 15 minutes.
Children starting at the age of 14 can self test. Children from ages 2 to 13 require the help of an adult.
Feel safe and confident whether or not you have symptoms of COVID-19.
The OHC COVID-19 Antigen Self Test detects both Omicron and Delta variants.
*Clinical data shows, OHC COVID-19 Antigen Self Test demonstrated a relative sensitivity of 91% ( 95% CI: 82.8 to 95.6%) at high viral loads (less than a cycle threshold (Ct)-value of 30) and relative specificity of 99% (95% CI: 95.2 to 99.6%). Clinical data analyzed using the minimum recommended number of low positives demonstrated that the test correctly identified 82.9% of positive samples and correctly identified 98.6% of negative samples. For more detailed information on test performance please see Section 13 of the Health Care Provider Instructions for Use. It is not possible to determine how much virus is in your sample prior to testing and a negative test does not rule out COVID-19 infection. A negative test also does not mean that you are not infectious. You can still have COVID-19 with a negative result from this test and infect other people. For this reason, it is recommended that you test at least twice (serial testing) when using this test. You should contact your healthcare provider to determine if additional testing with a highly sensitive COVID-19 molecular test is recommended. The performance of this test is still being studied in patients without signs and symptoms of respiratory infection and for serial screening. Performance may differ in these populations.
RAPID POINT-OF-CARE / INFECTIOUS DISEASES
Origin of Manufacture: KOREA
This product has the following special restrictions:
- Product is not returnable
- Product is not cancellable
If the above restriction does not apply, please see our View Similar Products for alternative products without this restriction.
Min. Order $50.00. Free shipping orders over $800.00 on regular priced items. $12.50 flat rate shipping GND (1-5 BUS DAYS) in continental USA. Exclusions may apply.
15% restocking fee, 10% administration fee. Shipping is paid for by the customer. Original packaging. No returns after 30 days. No Cancellations; No Returns on PPE, Personal Items or PPE-related products; All Sales Final. Not all products are eligible for returns. Exclusions may apply. Please refer to the "Restrictions" tab on the products listing page, i.e. where stated "Non-Returnable Item". All returns must be approved by our Returns Department. An e-mail notification will be issued regarding your return status and return instructions, should this apply. Any product returned for credit without an authorized RMA number clearly printed on the outside package or shipping label will be refused. Unauthorized returns will not be honored or accepted for credit.
Jant Pharmacal:
Jant Pharmacal is a leading provider of point of care medical diagnostics for physician offices, clinics, hospitals and laboratory practice settings.
Jant Pharmacal Corporation, established in 1986, is a leading provider of point-of-care medical diagnostic products. The Accutest and Accustrip product lines offer an extensive selection of CLIA Waived tests for use in physicians offices, clinics, hospitals, and laboratory practice settings.
Tests include pregnancy, Strep A infectious mononucleosis, H. pylori, TSH, immunological fecal occult blood tests (IFOBT), urinalysis readers and strips, as well as tests for sleep apnea.
In addition, Jant Pharmacal offers a full range of drug and alcohol on-site test kits for use in workplace, occupational health, school, and public safety settings. An extensive line of forensic field test kits are available for law enforcement and public safety.
Regardless of your professional practice setting, Accutest and Accustrip point of care diagnostic products provide you with the confidence you need to make clinical or forensic decisions. Jant Pharmacal's point of care diagnostic products are FDA cleared and are backed by over 20 years of experience and industry leadership.
There are no reviews for this product yet.